University of Birmingham - Proximity to Discovery 2017

Lead Research Organisation: University of Birmingham

Abstract

Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.

Technical Summary

The MRC Proximity to Discovery scheme awards universities funds to help develop new collaborations, and ways of exchanging knowledge and skills. The awards can be used to support activities that promote the value of academic-industry partnership, and enhance academic and industry researchers’ understanding of each other’s needs and capabilities. This may be through people exchanges, creation of technology demonstrators, showcase events, commercialisation workshops and ‘entrepreneurs in residence’ schemes. Such exchanges of knowledge and skills will boost the most fruitful collaborations between UK universities and life science companies.

Publications

10 25 50
 
Description Barts Charity
Amount £87,040 (GBP)
Organisation Barts Charity 
Sector Charity/Non Profit
Country United Kingdom
Start 11/2020 
End 10/2025
 
Description Birmingham CRUK Centre local support
Amount £18,050 (GBP)
Funding ID C17422/A25154 
Organisation Cancer Research UK 
Sector Charity/Non Profit
Country United Kingdom
Start 04/2018 
End 12/2018
 
Description CRUK Cancer Immunology Project Award
Amount £286,421 (GBP)
Funding ID C54019/A27535 
Organisation Cancer Research UK 
Sector Charity/Non Profit
Country United Kingdom
Start 02/2019 
End 01/2022
 
Description Department of Health and Social Care / University of Oxford
Amount £269,735 (GBP)
Organisation Department of Health (DH) 
Sector Public
Country United Kingdom
Start 11/2020 
End 10/2021
 
Description Development of Anti-viral Air Filters to Protect Passengers on Trains
Amount £17,908 (GBP)
Organisation Royal Academy of Engineering 
Sector Charity/Non Profit
Country United Kingdom
Start 06/2020 
End 06/2021
 
Description Dissecting the dynamic changes in the innate immune cells of tumours to enhance immune checkpoint blockade therapies
Amount £20,000 (GBP)
Organisation AstraZeneca 
Department MedImmune
Sector Private
Country United Kingdom
Start 09/2018 
End 09/2022
 
Description Industry funding
Amount £207,500 (GBP)
Organisation Principia Biopharma 
Sector Private
Country United States
Start 03/2020 
End 11/2021
 
Description LifeArc
Amount £420,746 (GBP)
Organisation LifeArc 
Sector Charity/Non Profit
Country United Kingdom
Start 07/2019 
End 12/2022
 
Description Ministry of Defence
Amount £134,000 (GBP)
Organisation Ministry of Defence (MOD) 
Sector Public
Country United Kingdom
Start 12/2020 
End 11/2021
 
Description Patient-reported outcomes assessment to support accelerated access to advanced cell and gene therapies: PROmics
Amount £1,185,446 (GBP)
Funding ID 104777 
Organisation Innovate UK 
Sector Public
Country United Kingdom
Start 12/2018 
End 03/2021
 
Description Rapid Design of Bioinspired Alloys - From Modelling to Manufacture
Amount £1,185,027 (GBP)
Organisation Medical Research Council (MRC) 
Sector Public
Country United Kingdom
Start 11/2021 
End 10/2025
 
Description Research Development Fund
Amount £4,500 (GBP)
Funding ID Harrison 
Organisation University of Birmingham 
Sector Academic/University
Country United Kingdom
Start  
 
Description Revealing antitumor T cell recruitment and recirculation in vivo to optimise therapeutic intervention
Amount £286,421 (GBP)
Organisation Cancer Research UK 
Sector Charity/Non Profit
Country United Kingdom
Start 02/2019 
End 01/2022
 
Description Topical delivery of Mitia drug using Cell Penetrating Peptide
Amount £509,997 (GBP)
Organisation Macregen 
Sector Private
Country United States
Start 03/2018 
End 09/2019
 
Description UKRI COVID-19 Rapid Response Rolling Call
Amount £708,036 (GBP)
Funding ID MR/W002663/1 
Organisation United Kingdom Research and Innovation 
Sector Public
Country United Kingdom
Start 02/2021 
End 07/2022
 
Description Wellcome ISSF
Amount £170,486 (GBP)
Funding ID ISSF3 HC3 
Organisation Wellcome Trust 
Sector Charity/Non Profit
Country United Kingdom
Start 09/2018 
End 09/2022
 
Description Wellcome ISSF Continuity Award
Amount £28,373 (GBP)
Organisation Wellcome Trust 
Sector Charity/Non Profit
Country United Kingdom
Start 01/2020 
End 12/2020
 
Description Wellcome Translational Development Fund (UoB internal)
Amount £18,332 (GBP)
Funding ID TDF 1.2 
Organisation Wellcome Trust 
Sector Charity/Non Profit
Country United Kingdom
Start 11/2020 
End 06/2021
 
Description Wellcome Translational Development Fund (UoB internal)
Amount £33,592 (GBP)
Funding ID TDF 1.1 
Organisation Wellcome Trust 
Sector Charity/Non Profit
Country United Kingdom
Start 01/2020 
End 03/2021
 
Description Worldwide Cancer Research
Amount £170,685 (GBP)
Organisation Worldwide Cancer Research 
Sector Charity/Non Profit
Country United Kingdom
Start 04/2021 
End 04/2023